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Summary Inability to use inhalers effectively is known to adversely affect the
delivery of drug. It is assumed that increasing competence to use inhalers will lead to
improved drug delivery. However many subjects appear competent (are able to use a
device effectively) but contrive to use the device in a sub-optimal way in routine
use. This study aimed to explore levels of True device compliance, that is the extent
to which devices are used effectively in routine use, and to explore the influences of
age and device on this parameter. The ability of 53 asthmatic patients aged 1–88
years to use their corticosteroid inhaler was assessed by a single investigator. In
addition information regarding patient behaviour in routine practice was explored in
a structured interview. True device compliance was defined to occur when a subject
was rated competent and did not report contrivance. Competence was related to
device type. All subjects using a holding chamber[pMDIþHC] (N ¼ 21) or breath
activated inhaler (N ¼ 5) could demonstrate an adequate technique compared with
only 9 (47%) of those prescribed a pMDI. However only 4 (19%) prescribed a pMDIþHC
were true device compliant with the majority regularly using the pMDI alone while
(42%) of those prescribed a pMDI were True device compliant. Since 82% of patients
over 65 were prescribed pMDI alone, and 92% of patients up to 5 years were
prescribed pMDIþHC, True device compliance was low among both groups. Only 33%
of patients over 65 prescribed pMDIs were able to use them competently. Lack of
competence, particularly in the elderly, and contrivance, particularly common
amongst those using holding chambers, are two important but independent
impediments to effective inhaled therapy.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
The introduction of an effective inhaled corticos-
teroid (ICS) almost 30 years ago1 transformed the
management of asthma. The use of these agents
results in a significant reduction in morbidity with
reduced daytime and night time symptoms, im-
proved exercise tolerance and, importantly, fewer
and less severe exacerbations.2,3 In addition they
have probably led to a fall in mortality.4
However to be effective these drugs must be
regularly delivered to the lungs via the airways in
sufficient quantities to have a therapeutic effect
and failure to do so results in increased morbidity.5–7
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In order to achieve effective delivery a number of
steps are required. The patients must first be
provided with a device that generates aerosolised
drug with the majority of drug particles having a
mass median aerosolised diameter of 1–5 mm as
particles in this size range are most likely to deposit
in the lungs.8 The patient then must both use their
inhalers regularly [comply with or adhere to a
suggested treatment regimen] and use the device
in a specific manner to optimise drug delivery.
Failure to use an inhaler optimally [poor device
compliance] may result in very low levels of drug
delivery to the lungs or indeed may result in
complete failure of drug delivery9 even when the
patient adheres to the suggested regimen. Failure
to use a device effectively may be due to an
inability to use a device effectively [lack of
competence] or to a deliberate use of the device
in manner that is sub-optimal [contrivance]. In the
later situation the patient can demonstrate effec-
tive use of the device but chooses to use it in a
different, inefficient, manner.
It is recognised that poor regimen compliance is
common in all diseases and does not appear to be
related to age, sex, disease, educational attain-
ment, understanding of disease or disease sever-
ity.10 Unfortunately there has been little evidence
that health care professionals can significantly
influence regimen compliance with the possible
exception of interventions immediately following
an acute episode such as a hospital admission.
However, as noted above, even when patients
comply or adhere to a treatment regime they
frequently fail to derive significant therapeutic
benefit due to poor device compliance. There have
been many studies indicating that many patients
and health care professionals do not possess the
competence to use devices effectively.11–20 Usually
this is because they have not been taught effec-
tively. In order to address this problem patient
education programmes recommend training pa-
tients in correct inhaler technique and where
necessary transferring patients to more appropri-
ate device. Implicit in this approach is a belief that
improved competence will result in improved
device compliance leading to improved therapeutic
outcomes. However there are few studies support-
ing this assumption. Anecdotal reports suggest that
many patients who are able to demonstrate
competence in the clinic setting contrive to use
the device ineffectually in routine practice. Ob-
vious examples are not using a holding chamber
when prescribed one for use with a pMDI and
stopping inhaling once a breath actuated inhaler
has been triggered. This form of behaviour in which
a subject knows how to perform an action
effectively but chooses or contrives to use a
different ineffectual technique is known as con-
trivance and is observed in many setting. For
example, doctors know why they should wash their
hands when moving from patient to patient on a
ward round, can demonstrate competence in doing
so in front of the infection control nurse but all to
often contrive not to do so when they feel they are
not being observed.21
While there are many previous studies assessing
patient’s competence we are not aware of any
studies that have specifically sought to explore the
possibility that significant numbers of patients may
modify their inhaler technique in routine practice
when not being observed by a health care profes-
sional. This study aimed to explore the possible
influences of age and device on the ability of
patients to use inhalers effectively. In addition we
aimed to explore whether patients routinely
modified their inhaler technique outside the clinic
setting.
Methods
A single individual from outside the respiratory
teams (VKB) interviewed a total of 53 asthmatic
subjects aged 1–88 years recruited from asthma
clinics and inpatients at the Sheffield’s Children’s
and Northern General Hospitals. Patients and/or
parents were reassured that their responses would
remain confidential. All patients were routinely
taking inhaled corticosteroids for chronic asthma.
Patients were asked to demonstrate how they
used their ICS inhaler and their ability to use the
device effectively was assessed by the investigator.
Inhaler technique was assessed as using a standar-
dised checklist (see Table 1) based on standard
recommendations. Patients were deemed to be
competent i.e. to have an adequate technique if
they (1) did not make a major error such as failing
to prime a DPI or have significant hand breath co-
ordination errors when using a pMDI or (2) did not
make more than one more minor error such as
failing to shake a pMDI before use or omit a breath
hold.
Subjects were subsequently asked if this was the
technique used at home or whether they modified
their technique in routine use. If they did modify
their technique they were asked to explain why.
Patients were defined as using Contrivance if they
were able to demonstrate that they were compe-
tent to use their device effectively but reported
that they frequently altered their inhaler techni-
que when outside the clinic setting.
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Patients were assessed as True device compliant
if they were competent and if they did not report
modifying their technique during routine use out-
side the clinic.
Having identified contrivance as a significant
problem amongst children using holding chambers
a discussion regarding the impact of modifying
inhaler technique outside the clinic setting was
incorporated into the routine assessment during
clinic visits. Two years after the initial study we
assessed the impact of this on levels of contrivance
again using an outside investigator (HG) who
interviewed 30 children and their carers. All the
children were using pMDI and holding chamber to
deliver their ICS. Sixteen were aged 2–6 years, 14
aged 7–16 years. In addition being asking about
their use of the spacer they were also asked about
their adherence to the recommended treatment
regime.
The study was approved by the local Research
Ethics Committee.
Results
Details regarding patient ages, devices used,
numbers with adequate technique and overall
device compliance are shown in Table 2. Eighteen
of 27 children aged 1–15 years and 3 of 26 adults
had been prescribed a holding chamber.
Competence was found to be significantly related
to age and was worse in the elderly than the other
age groups. Of 9 patients over 65 years prescribed a
pMDI only 1 subject had a completely adequate
technique (two more made minor errors and were
classed as competent). By comparison, amongst
those aged 16–65 years and prescribed MDIs, 7
(70%) were classed as competent. The three most
dramatic examples of lack of competence were
manifest by two patients who sprayed the pMDI on
their chest and one who failed to remove the cap.
The most common error was poor co-ordination
between actuating the device and inhaling. One
child using a Turbohaler failed to prime the device.
Less important errors included omitting the breath
hold and failing to shake the canister before use.
The commonest minor error with the spacer was
failing to shake the pMDI. Despite these examples
of poor competence all subjects believe that their
technique was correct.
Contrivance was very common particularly
among those prescribed a holding chamber. One-
hundred percent of all subjects using a holding
chamber were competent (could demonstrate a
good or adequate technique). However 81% of
these, including the parents of 10 of 11 children
under 5 years of age, stated that they frequently
did not use the holding chamber to administer ICS.
The commonest reason given for not using the
holding chamber was that the parent or patient was
‘too busy’ or in a rush. Four subjects using a pMDI
and the one using a breath actuated pMDI described
deliberately omitted the breath hold because ‘it
took too long’.
True device compliance was lowest in the young-
est [due to contrivance] and oldest [due to lack of
competence]age groups, but the effect of aged did
not reach statistical significance.
In the follow up study limited to children using
pMDIs and holding chambers only 2 of 30 (7%)
patients/parents indicated that they regularly
omitted the holding chamber and a further 2 (7%)
used the pMDI alone occasionally. All four subjects
were older than 7 years of age. Sixty six percent of
all the children reported missing at least one dose a
week and there did not appear to be any significant
trends in self reported levels of adherence across
the age spectrum. However self reported levels of
adherence were much lower in the 4 subjects
reporting occasional or frequent use of the pMDI
without a spacer. These subjects reported that they
were not convinced that their treatment was
helping them.
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MDI
Remove mouthpiece cap
Shake device
Hold inhaler upright
Breath out gently
Close lips around mouthpiece
Breath in slowly over several seconds
Actuate canister as patient starts to inhale
Hold breath for 10 s
pMDI with holding chamber
As above with addition of
Assemble pMDI and holding chamber correctly
Single actuation of canister followed by
1 slow inspiratory breath with breath hold [for
older subjects]
or
breathing in and out of holding chamber for 10 s
Dry powder inhaler
Remove cap
Prime device effectively
Exhale to residual volume
Place mouthpiece between lip
Inhale forcefully and deeply
Hold breath for as long as comfortable
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Discussion
This study highlights for the first time the need to
consider three independent factors when trying to
assess whether a patient is using an inhaler device
effectively. It is well known that poor regimen
compliance [adherence] can have a major impact
on therapeutic outcomes. It has also been well
established that lack of competence will result in
ineffectual drug delivery to the lungs but no
previous study has highlighted the need to consider
whether contrivance may also be adversely affect-
ing therapeutic outcomes. True device compliance
involves both being competent and using the device
effectively when not being observed [not contriving
to use an ineffective technique]. The high levels of
contrivance identified in this study, particularly
amongst those using holding chambers, would
indicate that that sub-optimal responses to therapy
will be observed in many patients even when they
are compliant with a treatment regimen and can
demonstrate a good inhaler technique [are compe-
tent] when seen in the clinic.
The low levels of competence amongst the
elderly using portable inhalers appears to be the
major impediment to effective therapy amongst
those in this age group. This was not a surprise
since previous studies have also highlighted the low
levels of competence with inhalers amongst the
elderly.12–15 The lack of competence amongst many
elderly patients reflects the fact that current
devices are not intuitive to use and require
considerable cognitive ability to use effectively.
Cognitive issues are particularly a problem in this
age group.12–15,22 The high level of pMDI use in this
age group is also likely to have contributed to the
low levels of competence. In contrast to the results
presented by the Kamps et al.20 we found that most
children attending the clinic were competent to
use their inhalers effectively and we believe this
reflects the effective intervention of our respira-
tory nurses.
Despite the high levels of competence we found
that true device compliance amongst children
included in the principle study was similar to that
in the elderly due to high levels of contrivance.
Overall 81% of all subjects using a holding chamber
reported regularly using the pMDI alone and this
behaviour was seen in all age groups. Although all
parents of pre-school children were able to use a
holding chamber adequately, the majority de-
scribed regularly actuating the pMDI directly into
the child’s mouth when administering inhaled
corticosteroids despite knowing the reasons for
using the holding chamber. These results are very
similar to those reported in a study involving adult
subjects in whom the rate of ‘spacer disuse’ was
reported as 67%.23 The perceived ‘inconvenience’
of using the spacer out weighed all the information
provided by health care professionals. In clinical
practice contrivance is also observed with other
devices such intentionally omitting a breath hold
with a pMDI and stopping inhaling once a breath
actuated pMDI’s has fired. Such finding calls into
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Table 2
Age range
(yrs)
Number Devices used N (%) competent
(adequate technique)
N [%] True device
compliant
1–5 12 pMDIþHC 11 11 (100) 1 (9
DPI 1 1 (100) 1 (100)
Total 12 (100) 2 (17)
7–15 15 pMDIþHC 7 7 (100) 2 (29)
DPI 4 2 (50) 2 (50)
BA pMDI 4 4 (100) 3 (75)
Total 13 (86) 7 (47)
16–64 15 pMDI 10 7 (70) 5 (50)
pMDIþHC 2 2 (100) 1 (50)
DPI 2 2 (100) 2 (100)
BA pMDI 1 1 (100) 1 (100)
Total 12 (80) 9 (60)
65–88 11 pMDI 9 3 (33) 3 (33)
pMDIþHC 1 1 (100) 0 (0)
DPI 1 1 (100) 1 (100)
5 (46) 4 (36)
Device compliance¼% subject who were competent and did not modify their technique regularly.
BA pMDI: Breath actuated pMDI.
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question the uncritical recommendations that all
subjects should be prescribed a pMDI and holding
chamber.24 Fortunately some guidelines have taken
into account the influence of individual patient
behaviour on outcomes and while recommending
holding chambers recognise that other devices such
as dry powder inhalers may be more appropriate for
individual patients.25,26
Contrivance is common in many settings. Those
with a driving licence know that it is safer to drive
within the speed limit and will demonstrate this
skill during a driving test. However many will
frequently contrive to drive in a dangerous manner
because they are convinced that their driving
techniques are such that they can ignore the advice
of others. As noted above this pattern of behaviour
is frequently observed amongst doctors who under-
stand that hand washing can reduce the spread of
infective organisms and can show that they have
the competence to effectively wash their hands but
time and again they contrive to examine patients
without first washing their hands.21,27
Self reporting of modification of behaviour is
likely to underestimate the true level of contri-
vance but we feel this may have been minimised by
the use of a non-medical investigator from outside
the clinical team and assurances that answers
would remain confidential. Being aware of such
behaviour is important in that it can then be
addressed as part of the routine clinical consulta-
tion. The data from the follow up study
suggests that levels of contrivance amongst chil-
dren using holding chambers appeared to fall
dramatically to only 14% of subjects once this type
of behaviour was acknowledged and addressed in
the clinic.
Contrivance may not only contribute to thera-
peutic failures but may also significantly alter the
‘therapeutic index’ of inhaled corticosteroids.
Higher upper airways deposition due will result in
an increased risk of local side effects such as
hoarseness or candida infection. In addition the
potential for systemic side effects of ICS such as
beclomethasone, which have a relatively high
systemic availability when swallowed,28 may be
increased. It is very likely that many children are on
unnecessarily high prescribed doses of ICS to
compensate for the poor delivery to the lungs
when they contrive not to use their spacer. As a
result, the dose of swallowed ICS will be signifi-
cantly increased both because the patient actuates
the pMDI directly into their mouth and because the
dose has been increase to compensate for their
poor technique.
Those involved in the management of asthmatic
patients need to be aware that simply assessing a
patient’s competence in the clinic will significantly
over estimate true device compliance. Many
patients will contrive to misuse their inhalers even
when they are competent with the device, parti-
cularly when using pMDIs with holding chambers.
Patients and/or their carers should be asked about
their use of the device in routine practice as well as
being asked to demonstrate that they can use the
device effectively.
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